Deborah H. Telman's Insider Trades & SAST Disclosures

Deborah H. Telman's most recent trade in Gilead Sciences, Inc. was a trade of 8,229 Restricted Stock Unit done . Disclosure was reported to the exchange on July 25, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2025 8,229 21,646 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2025 8,229 46,544 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.20 per share. 25 Jul 2025 3,823 42,721 (0%) 0% 116.2 444,233 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2025 514 29,875 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2025 514 38,315 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 1,313 30,389 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2025 1,313 38,231 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.09 per share. 10 Jun 2025 430 37,801 (0%) 0% 110.1 47,339 Common Stock
Atricure Inc
Deborah H. Telman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2025 5,401 22,184 (0%) 0% 0 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2025 514 37,076 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2025 514 31,702 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.17 per share. 25 Apr 2025 158 36,918 (0%) 0% 103.2 16,301 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 33,940 33,940 - - Non-qualified Stock Option (Right to Buy)
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2025 7,680 32,216 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2025 3,343 37,692 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2025 3,343 24,356 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.21 per share. 10 Mar 2025 1,130 36,562 (0%) 0% 117.2 132,447 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2025 12,371 34,011 (0%) 0% 0 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2025 515 21,827 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2025 515 27,879 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.07 per share. 25 Jan 2025 187 21,640 (0%) 0% 93.1 17,404 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 639 28,394 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 639 21,618 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.34 per share. 10 Dec 2024 306 21,312 (0%) 0% 92.3 28,256 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2024 514 29,033 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2024 514 21,221 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.00 per share. 25 Oct 2024 242 20,979 (0%) 0% 89 21,538 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2024 639 21,014 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2024 639 29,547 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.44 per share. 10 Sep 2024 307 20,707 (0%) 0% 81.4 25,002 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2024 8,230 20,375 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2024 8,230 30,186 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.51 per share. 25 Jul 2024 2,917 11,631 (0%) 0% 76.5 223,180 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2024 514 12,145 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2024 514 38,416 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2024 638 14,752 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2024 638 38,930 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.25 per share. 10 Jun 2024 204 14,548 (0%) 0% 65.3 13,311 Common Stock
Atricure Inc
Deborah H. Telman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2024 7,788 16,783 (0%) 0% 0 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2024 515 39,568 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Apr 2024 515 14,272 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.27 per share. 25 Apr 2024 158 14,114 (0%) 0% 65.3 10,313 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2024 54,980 54,980 - - Non-qualified Stock Option (Right to Buy)
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2024 10,815 40,083 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2024 2,555 14,603 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2024 2,555 29,268 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.12 per share. 10 Mar 2024 846 13,757 (0%) 0% 75.1 63,552 Common Stock
Gilead Sciences
Deborah Telman H. EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 4,646 11,728 (0%) 0% 0 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2024 514 7,276 (0%) 0% - Common Stock
Gilead Sciences
Telman H. Deborah EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2024 514 31,823 - - Restricted Stock Unit
Gilead Sciences
H. Deborah Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. 25 Jan 2024 194 7,082 (0%) 0% 80.2 15,565 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2023 514 32,337 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2023 514 7,005 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.39 per share. 25 Oct 2023 243 6,762 (0%) 0% 78.4 19,049 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2023 8,231 34,909 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2023 8,231 8,607 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.23 per share. 25 Jul 2023 4,174 4,433 (0%) 0% 77.2 322,358 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2023 2,058 6,491 (0%) 0% - Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2023 2,058 32,851 - - Restricted Stock Unit
Atricure Inc
Deborah H. Telman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 3,186 8,995 (0%) 0% 0 Common Stock
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2023 46,605 46,605 - - Non-qualified Stock Option (Right to Buy)
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2023 10,220 43,140 - - Restricted Stock Unit
Gilead Sciences
Deborah H. Telman EVP, Corporate Affairs & GC Grant, award, or other acquisition of securities at price $ 56.38 per share. 15 Feb 2023 376 376 (0%) 0% 56.4 21,199 Common Stock
Atricure Inc
Deborah H. Telman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 3,564 5,809 (0%) 0% 0 Common Stock
Organon & Co.
Deborah H. Telman EVP GC & Corporate Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2022 4,431 8,987 - - Common Stock
Organon & Co.
Deborah H. Telman EVP GC & Corporate Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 May 2022 4,431 4,431 - - Restricted Stock Units
Organon & Co.
Deborah H. Telman EVP GC & Corporate Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.44 per share. 04 May 2022 1,299 7,688 - 32.4 42,140 Common Stock
Organon & Co.
Deborah H. Telman Gen Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 39,682 39,682 - - Stock Option (right to buy)
Organon & Co.
Deborah H. Telman Gen Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 12,882 12,882 - - Restricted Stock Units
Organon & Co.
Deborah H. Telman Gen Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2021 22,321 22,321 - - Stock Option (Right to Buy)
Organon & Co.
Deborah H. Telman EVP GC & Corporate Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. 05 Aug 2021 6,445 6,445 - 28.6 184,520 Common Stock
Organon & Co.
Deborah H. Telman EVP GC & Corporate Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2021 6,445 12,892 - - Restricted Stock Units
Organon & Co.
Deborah H. Telman EVP GC & Corporate Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.63 per share. 05 Aug 2021 1,889 4,556 - 28.6 54,082 Common Stock
Atricure Inc
Deborah H. Telman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 2,245 2,245 (0%) 0% 0 Common Stock
Organon & Co.
Deborah H. Telman General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 103,095 103,095 - - Stock Option (Right to Buy)
Organon & Co.
Deborah H. Telman General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 19,337 19,337 - - Restricted Stock Units
Organon & Co.
Deborah H. Telman General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 17,624 17,624 - - Restricted Stock Units
Organon & Co.
Deborah H. Telman General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 13,296 13,296 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades